Morning Recap
Market Commentary
Everyone’s ignoring that while silver is popping to fresh highs, industrial demand is projected to slip. That’s a hell of a setup for a mean reversion if EV and photovoltaic installs don’t meet lofty forecasts. Throw in a skittish Fed watching inflation data, and you’ve got a potential squeeze followed by a reverse rip that’ll knock novice traders flat.
Strip out the glamour around Ozempic 2.0 pills and you see the same playbook pharma’s using for their biotech short squeezes. Now throw in Profound Medical’s AI-powered BPH module at RSNA, and you’ve got two ‘next-gen’ health stories vying for capital that’s already chasing momentum. That’s not a coincidence—it’s a reallocation wave that could leave walking-dead injectables trading like dusty relics.
If you’re tired of the biotech merry-go-round, shift your focus to sectors with predictable cash flow. The cardiovascular devices market is poised to reach USD 110.39 billion by 2029, and Singular’s cloud-based medtech platform is stacking FDA filings. Stake your claim now—these aren’t lottery tickets, they’re revenue machines.
📈 Breaking Financial News
‘Ozempic 2.0' is on the way and could completely change weight loss drugs
A new version of Ozempic is in the works for next year and is subject to FDA approval. The manufacturers of Ozempic and Mounjaro are planning to launch a new weight loss method in 2026. While Ozempic remains a GLP-1 medicine for adults with Type-2 diabetes, an…
What is Ozempic 2.0? Will it be a gamechanger for weight loss? Here's all you need to know
The manufacturers of Ozempic and Mounjaro are creating oral weight loss medications that could change treatment methods. These daily pills, pending FDA approval, reportedly show significant results in trials.
Bitcoin Recovery Gains Momentum Past $90K, Yet Analysts Warn the Upside Could Be Fragile
Bitcoin has climbed back above the $90,000 mark, recovering sharply after last week’s slump to near-$80,000. The world’s largest crypto surged as much as 4% in 24 hours, briefly touching $91,200, boosted by renewed market optimism, improving liquidity, and gr…
The pharma stocks to remain in focus in Friday’s trade (November 28, 2025)
Pharma stocks to watch: Zydus gains FDA approval, Emcure faces GST inspection, and Bajaj appoints new COO.
Bitcoin In Serious Danger of Disappearing From Exchanges…
This could be the biggest “supply shock” in financial history! Bitcoin on exchanges is being bought up faster than miners can mine it. The smart money like BlackRock, Goldman Sachs, and MicroStrategy are doubling, tripling, quadrupling down. And they're doing everything they can to buy up ONE altcoin before prices blast-off like a Space X rocket. Discover the ONE altcoin smart money is buying up before Bitcoin's supply shock.
🔍 Market Analysis & Insights
Barclays Raises Syndax (SNDX) PT to $35 on Positive Management Update, Model Rerating
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks with huge upside potential. On November 24, Barclays raised the firm’s price…
Next-level Ozempic is coming — inside the new era of weight-loss drugs about to drop
Blockbuster weight-loss shots are undergoing a major makeover.
What is Ozempic 2.0? New pills promise easier dosing
Millions of people use injectable drugs like Wegovy to reach healthier weights, but weekly injections don’t work for everybody’s lifestyle or budget. That’s why experimental pills that could achieve similar results are drawing significant attention from patie…
Global Cardiovascular Devices Market to Reach USD 110.39 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL, Nov. 28, 2025 (GLOBE NEWSWIRE) — Rising CVD prevalence, rapid adoption of minimally invasive procedures, and strong innovation pipelines position the sector for sustained 7.3% CAGR growth.The global cardiovascular devices market, valued at …
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
New BPH module and clinical data reinforce the TULSA Procedure’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profo…
Buffett, Gates and Bezos Quietly Dumping Stocks-Here's Why
Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It's something we haven't see in America for more than a century. For the full story, click here.
💰 Investment Opportunities
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
New BPH module and clinical data reinforce the TULSA Procedure’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption New BPH module and clinical data reinforce the TULSA Procedure’s versatility in prostate disea…
What is Ozempic 2.0? Is it the future of weight loss? Here's what you need to know about the new drug
A new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly, has shown significant weight reduction in early trials. It offers a needle-free alternative to current injectables like Ozempic and …
Singular seeks US FDA application for cloud-based medtech platform
Singular Health Group has formally submitted a 510(k) notification to the US Food and Drug Association to sell its innovative cloud based 3DICOM imaging technology into the giant US medical technology market.
Wealth advisors are zeroing in on 4 ‘promising' safe growth sectors. Why investors are paying attention
Do these sectors already have a place in your portfolio?
XRP Reserves On Binance Collapse To Record Lows: Investors Move Toward Long-Term Holding
XRP is under intense selling pressure as the broader crypto market enters a decisive stage marked by fear, uncertainty, and a rapid shift in investor sentiment. With Bitcoin struggling to recover and altcoins posting steep losses, many analysts are warning th…